Literature DB >> 35402654

Parkinson's Disease Medication Prescribing and Administration During Unplanned Hospital Admissions.

Georgia Richard1, Aine Redmond1, Maitreyi Penugonda2, David Bradley1,3.   

Abstract

Background: Parkinson's disease (PD) is the second most common neurodegenerative disease with a lifetime risk of 1% to 3%. Treatment includes supplementation of central dopaminergic neurotransmission with levodopa preparations and dopamine agonists. Misprescribing and delayed administration of these medications on admission to hospital can result in increased morbidity and mortality. Objective: We aimed to assess the accuracy of time-critical PD medication prescribing and administration during unplanned hospital admissions.
Methods: Patients admitted during a 15-month period with PD on time-critical PD medications were included. Their electronic patient records were compared with the pharmacist medication reconciliation to assess accuracy of admission prescribing. Accuracy of administration was assessed by comparing the time medications were administered to the time they were due. Statistical Package for Social Sciences software was used to perform statistical analysis in this study.
Results: A total of 102 admissions of 70 patients (67% men) were included for analysis. These patients were on 1.6 ± 0.8 time-critical PD medications before admission, accounting for 4.1 ± 1.8 administrations per day. Time-critical medications were prescribed correctly on admission in 50% of admissions, with errors in medication timing most common (31.6%). Of all doses, 51.7% were administered >30 minutes late, and 29.7% of doses were administered >1 hour late. Female sex, a higher number of medications, and more frequent administrations were significantly associated with the rate of medication error.
Conclusion: This study demonstrates high rates of inaccurate prescribing and inaccurate administration of time-sensitive medication in a cohort of patients with PD admitted acutely to hospitals.
© 2022 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; administration; prescribing

Year:  2022        PMID: 35402654      PMCID: PMC8974884          DOI: 10.1002/mdc3.13408

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  8 in total

Review 1.  Pathophysiology of the basal ganglia in Parkinson's disease.

Authors:  J A Obeso; M C Rodríguez-Oroz; M Rodríguez; J L Lanciego; J Artieda; N Gonzalo; C W Olanow
Journal:  Trends Neurosci       Date:  2000-10       Impact factor: 13.837

Review 2.  Pharmacokinetics and pharmacodynamics of levodopa.

Authors:  John G Nutt
Journal:  Mov Disord       Date:  2008       Impact factor: 10.338

Review 3.  The epidemiology of Parkinson's disease: risk factors and prevention.

Authors:  Alberto Ascherio; Michael A Schwarzschild
Journal:  Lancet Neurol       Date:  2016-10-11       Impact factor: 44.182

4.  Delayed Administration and Contraindicated Drugs Place Hospitalized Parkinson's Disease Patients at Risk.

Authors:  Matthew Grissinger
Journal:  P T       Date:  2018-01

5.  Medication management in people with Parkinson's disease during surgical admissions.

Authors:  C P Derry; K J Shah; L Caie; C E Counsell
Journal:  Postgrad Med J       Date:  2010-06       Impact factor: 2.401

6.  Assessment of appropriate medication administration for hospitalized patients with Parkinson's disease.

Authors:  Jyhgong Gabriel Hou; Laura J Wu; Suzanne Moore; Constance Ward; Michele York; Farah Atassi; Linda Fincher; Naomi Nelson; Aliya Sarwar; Eugene C Lai
Journal:  Parkinsonism Relat Disord       Date:  2012-01-09       Impact factor: 4.891

7.  Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease.

Authors:  Amit S Kulkarni; Rajesh Balkrishnan; Roger T Anderson; Heather M Edin; Jeff Kirsch; Mark A Stacy
Journal:  Mov Disord       Date:  2008-02-15       Impact factor: 10.338

8.  Missing dosages and neuroleptic usage may prolong length of stay in hospitalized Parkinson's disease patients.

Authors:  Daniel Martinez-Ramirez; Juan C Giugni; Christopher S Little; John P Chapman; Bilal Ahmed; Erin Monari; Aparna Wagle Shukla; Christopher W Hess; Michael S Okun
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.